|
PSCI-25-016 |
ACCL1931: A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy |
|
PSCI-25-018 |
NRG-HN014:Randomized Phase III Trial Of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-Of-Care Treatment For Resectable Stage Iii/Iv Cutaneous Squamous Cell Carcinoma |
|
PSCI-25-028 |
Lotam: A Randomized, Phase III Clinical Trial Of Low-Dose Tamoxifen For Selected Patients With Molecular Low-Risk Early-Stage Breast Cancer |
|
PSCI-25-037 |
Trial Access: Uncovering Barriers in Clinical Trials for Cancer Care in the Penn State Cancer Institute patient population survey feasibility study |
|
PSCI-25-060 |
NRG-CC014: Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT) |
|
PSHCI-08-065 |
Biologic Studies of Experimental Anti-Cancer Therapeutics in Human Leukemia Cells |
|
PSHCI-08-079 |
Children's Lives Include Moments of Bravery (CLIMB) |
|
PSHCI-09-052 |
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies |
|
PSHCI-10-061 |
General Protocol for the Acquisition of Whole Blood for the Detection and Characterization of Circulating Tumor Cells and/or Tumor Specific Immunity/Immune Cell Activation for any Malignancy at any Stage of Disease |
|
PSHCI-11-010 |
Head and Neck Cells: Tissue Repository |
